Evidence map›Paper›PMID 37273666›Full record

ArticleClinical case reports2023

Mahmoud Sadeghi Haddad Zavareh, Hamed Mehdinezhad, Rahele Mehraeen, Mohammad Golparvar Azizi, Ali Tavakoli Pirzaman

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Clinical case reports · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mahmoud Sadeghi Haddad ZavarehInfectious Diseases and Tropical Medicine Research Center, Health Research Institute Babol University of Medical Sciences Babol Iran.
Hamed MehdinezhadDepartment of Internal Medicine, Rouhani Hospital Babol University of Medical Sciences Babol Iran.
Rahele MehraeenDepartment of Radiology, Rohani Hospital Babol University of Medical Sciences Babol Iran.
Mohammad Golparvar AziziStudent Research Committee Babol University of Medical Sciences Babol Iran.
Ali Tavakoli PirzamanStudent Research Committee Babol University of Medical Sciences Babol Iran.ORCID https://orcid.org/0000-0002-9426-7034
Babol University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although immunodeficient patients are less prone to develop Coronavirus disease 2019 (COVID-19)-mediated cytokine storm, secondary infections can cause serious complications in this vulnerable population. They are more likely to develop opportunistic infections that can mimic the symptoms of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Herein, we presented a 27-year-old male patient of SARS-CoV-2 infection, who was complicated with

Indexed as

COVID‐19multiple sclerosisPneumocystis jirovecii pneumoniarituximabSARS‐CoV‐2 infection

Identifiers

PMID37273666
PMCPMC10238708
OpenAlexW4379259662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.